These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Rationale for a triphasic oral contraceptive. Pasquale SA. J Reprod Med; 1984 Jul; 29(7 Suppl):560-7. PubMed ID: 6481710 [Abstract] [Full Text] [Related]
5. Current perspectives on combination oral contraceptives. Smith MA, Youngkin EQ. Clin Pharm; 1984 Jul; 3(5):485-96. PubMed ID: 6386284 [Abstract] [Full Text] [Related]
6. On 7/7/7 preferred for new patients by 47% of respondents. Contracept Technol Update; 1986 Sep; 7(9):101-4. PubMed ID: 12268337 [Abstract] [Full Text] [Related]
7. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives]. Cianci A, De Leo V. Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832 [Abstract] [Full Text] [Related]
8. Triphasics: have they fulfilled their promise? Weisberg E. Curr Ther (Seaforth); 1992 Jan; 33(1):11-6. PubMed ID: 12286973 [Abstract] [Full Text] [Related]
10. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data]. Gaspard U, Dubois M. Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606 [Abstract] [Full Text] [Related]
19. [How to choose an oral contraceptive in 1984]. Rozenbaum H. Contracept Fertil Sex (Paris); 1984 Nov; 12(11):1201-6. PubMed ID: 12266609 [Abstract] [Full Text] [Related]
20. [Oral contraception: disadvantages of estrogen reduction]. Denis C. Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238 [Abstract] [Full Text] [Related] Page: [Next] [New Search]